UNITED ~~STATES SECURITIES~~ STATESSECURITIES AND EXCHANGE ~~COMMISSION~~COMMISSIONWashington, DC 20549

WASHINGTON, D.C. 20549

FORM 8-K

~~CURRENT~~ Current ReportPursuant to ~~REPORT~~Section 13 or 15(d) of the Securities Exchange Act of 1934

~~Pursuant~~ Date toof Report ~~Section 13~~(Date orof ~~15(d~~earliest event reported) of: ~~the~~February ~~Securities~~25, ~~Exchange~~2015ProUroCare Medical ~~Act~~Inc.(Exact Name of ~~1934~~Registrant as Specified in its Charter)

Date of Report: March 12, 2014

Nevada

000-51774

20-1212923

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

6440 Flying Cloud Dr., Suite 101, Eden Prairie, Minnesota 55344 (~~Date~~Address of ~~earliest~~Principal ~~event~~Executive ~~reported~~Offices)(Zip Code)

~~ProUroCare~~ (952) 476-9093(Registrant’s Telephone ~~Medical~~Number, ~~Inc.~~Including Area Code)Not Applicable(Former Name or Former Address, if Changed Since Last Report)

(Exact name of registrant as specified in its charter)

Commission File Number: 000-51774

Nevada		20–1212923
(State or other jurisdiction of incorporation)		(IRS Employer Identification No.)

6440 Flying Cloud Drive, Suite 101, Eden Prairie, Minnesota 55344

(Address of principal executive offices, including zip code)

(952) 476–9093

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o ⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o ⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o ⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o ⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8 1.01. ~~Other~~Entry ~~Events~~into a Material Definitive Agreement.

On ~~March 12~~February 25, ~~2014~~2015, ProUroCare Medical, Inc. ~~issued~~(“ProUroCare”) entered into a ~~press~~Management ~~release~~Consulting ~~announcing~~Agreement ~~its~~(the ~~decision~~“Agreement”) towith ~~remove~~Advanta Management ~~its~~Consulting, ~~common~~Inc. ~~stock~~(“Advanta”). The ~~from~~Company ~~trading~~engaged onAdvanta ~~the~~to provide ~~OTCQB~~operational, administrative and tofinancial ~~deregister~~services ~~its~~to ~~common~~the Company. Under ~~stock~~the Agreement, ~~warrants~~the ~~and~~Company ~~units~~will ~~under~~provide ~~Section~~ a $85,000 retainer payment, $12~~(g) of~~,500 ~~the~~per ~~Securities~~month in consulting fees, and ~~Exchange~~a ~~Act~~22.5% equity ofstake ~~1934~~in (the ~~“Exchange~~Company ~~Act”)~~if a minimum of $3,000,000 ~~and~~of ~~suspend~~needed ~~its~~working capital ~~reporting~~is ~~obligations~~obtained ~~under~~through ~~Section 15(d)~~ the efforts of Advanta. If minimum interim funding, as defined in the ~~Exchange~~agreement, ~~Act~~is bynot ~~filing~~received awithin ~~Form 15~~150 ~~with~~days the Company may terminate the ~~Securities~~agreement ~~and~~with ~~Exchange~~no ~~Commission~~obligation to provide equity or any fees to Advanta. AIf ~~copy~~the Company is unsuccessful in obtaining $3,000,000 within 12 months, the Company has the option of terminating the ~~press~~agreement ~~release~~and iswill ~~attached~~have ~~hereto~~no asobligation ~~Exhibit 99~~for the equity stake and no further obligation for the retainer and monthly consulting fees beyond any money raised through the date of termination.1.

~~Item 9.01. Financial Statements and Exhibits.~~ SIGNATURES

~~(d) Exhibits~~ Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

99.1 Press Release date March 12, 2014

			ProUroCare Medical Inc.


		By:	/s/ Stanton D. Myrum
			Stanton D. Myrum
			Chief Executive Officer

Date:	February 25, 2015

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PROUROCARE MEDICAL INC. By: /s/ Alan Shuler Alan G. Shuler Chief Financial Officer and Secretary

Date: March 12, 2014

Filing Compare · ProUroCare Medical Inc.